Phase II study of subcutaneously administered 5-azacytidine (NSC-102816) in patients with metastatic malignant melanoma (Q39477150)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of subcutaneously administered 5-azacytidine (NSC-102816) in patients with metastatic malignant melanoma |
scientific article |
Statements
1 reference
Phase II study of subcutaneously administered 5-azacytidine (NSC-102816) in patients with metastatic malignant melanoma (English)
1 reference
Bellet RE
1 reference
Catalano RB
1 reference
Mastrangelo MJ
1 reference
Berd D
1 reference
1 January 1978
1 reference
1 reference
4
1 reference
1
1 reference
11-15
1 reference
Identifiers
1 reference
1 reference